Wearables-based walking program in addition to usual physiotherapy care for the management of patients with low back pain at medium or high risk of chronicity: A pilot randomized controlled trial.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
03
2021
accepted:
31
07
2021
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Although chronic low back pain (LBP) is a leading cause of disability and accounts for large costs, none of the available conventional treatments are clearly more favourable in treating people at increased risk of chronicity. To examine the feasibility and initial efficacy of a wearables-based walking intervention in addition to usual physiotherapy care in people with LBP at risk of chronicity. Twenty-six adult participants, diagnosed with non-specific LBP with medium or high risk of chronicity, were recruited from physiotherapy private practices. Participants were randomized into usual physiotherapy care (control, n = 14) and usual physiotherapy care plus a wearables-based walking intervention (experimental, n = 12). The intervention duration was 8 weeks. Feasibility outcomes included recruitment rate, adherence to the intervention, dropout rate, and serious adverse events reporting rate. Other outcomes included disability and pain (primary); and physical activity level, daily walking steps, depression, pain catastrophizing and fear of movement (secondary). The outcomes were assessed at baseline, post-intervention and 26 weeks post-randomization follow-up. Adherence of experimental participants with the prescribed walking program was moderate. Four participants dropped out during the intervention, and no serious adverse events were reported. Participants in the experimental group showed significant improvement in pain at 26 weeks (β = -0.38; 95% confidence interval (CI) -0.66, -0.10; P = .013), compared with the control group. No between-group differences were found for disability at any time point and pain immediately post-intervention. Experimental participants demonstrated post-intervention improvement in light-intensity (β = 156.71; 95% CI 86.79, 226.64; P < .001), moderate-intensity physical activity (β = 0.46; 95% CI 0.12, 0.80; P = .012), and daily walking steps (β = 7099.13; 95% CI 4522.93, 9675.32; P < .001). Experimental participants demonstrated post-intervention increase in pain catastrophizing (β = 0.52, 95% CI 0.18, 0.86; P = .006). No between-group differences were found for pain catastrophizing at 26 weeks and other secondary outcomes. Usual physiotherapy care plus a wearables-based walking intervention program was safe and moderately feasible, and provided significant reduction in pain at 26 weeks as well as increasing the total volume of light- and moderate-intensity physical activity, and daily walking steps immediately post-intervention.
Sections du résumé
BACKGROUND
Although chronic low back pain (LBP) is a leading cause of disability and accounts for large costs, none of the available conventional treatments are clearly more favourable in treating people at increased risk of chronicity.
OBJECTIVES
To examine the feasibility and initial efficacy of a wearables-based walking intervention in addition to usual physiotherapy care in people with LBP at risk of chronicity.
METHODS
Twenty-six adult participants, diagnosed with non-specific LBP with medium or high risk of chronicity, were recruited from physiotherapy private practices. Participants were randomized into usual physiotherapy care (control, n = 14) and usual physiotherapy care plus a wearables-based walking intervention (experimental, n = 12). The intervention duration was 8 weeks. Feasibility outcomes included recruitment rate, adherence to the intervention, dropout rate, and serious adverse events reporting rate. Other outcomes included disability and pain (primary); and physical activity level, daily walking steps, depression, pain catastrophizing and fear of movement (secondary). The outcomes were assessed at baseline, post-intervention and 26 weeks post-randomization follow-up.
RESULTS
Adherence of experimental participants with the prescribed walking program was moderate. Four participants dropped out during the intervention, and no serious adverse events were reported. Participants in the experimental group showed significant improvement in pain at 26 weeks (β = -0.38; 95% confidence interval (CI) -0.66, -0.10; P = .013), compared with the control group. No between-group differences were found for disability at any time point and pain immediately post-intervention. Experimental participants demonstrated post-intervention improvement in light-intensity (β = 156.71; 95% CI 86.79, 226.64; P < .001), moderate-intensity physical activity (β = 0.46; 95% CI 0.12, 0.80; P = .012), and daily walking steps (β = 7099.13; 95% CI 4522.93, 9675.32; P < .001). Experimental participants demonstrated post-intervention increase in pain catastrophizing (β = 0.52, 95% CI 0.18, 0.86; P = .006). No between-group differences were found for pain catastrophizing at 26 weeks and other secondary outcomes.
CONCLUSION
Usual physiotherapy care plus a wearables-based walking intervention program was safe and moderately feasible, and provided significant reduction in pain at 26 weeks as well as increasing the total volume of light- and moderate-intensity physical activity, and daily walking steps immediately post-intervention.
Identifiants
pubmed: 34437607
doi: 10.1371/journal.pone.0256459
pii: PONE-D-21-09195
pmc: PMC8389429
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0256459Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pain. 2006 Apr;7(4):261-71
pubmed: 16618470
Med Sci Sports Exerc. 2011 Feb;43(2):312-8
pubmed: 20543754
BMC Musculoskelet Disord. 2017 May 31;18(1):232
pubmed: 28569152
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Manipulative Physiol Ther. 1995 Feb;18(2):79-87
pubmed: 7790787
Int J Behav Nutr Phys Act. 2015 Dec 18;12:159
pubmed: 26684758
J Biomed Inform. 2013 Apr;46(2):259-65
pubmed: 23149159
JAMA. 2007 Nov 21;298(19):2296-304
pubmed: 18029834
Expert Rev Neurother. 2009 May;9(5):745-58
pubmed: 19402782
Pain. 1995 Sep;62(3):363-372
pubmed: 8657437
BMJ. 2007 Jun 9;334(7605):1204
pubmed: 17540909
Disabil Rehabil. 2019 Mar;41(6):622-632
pubmed: 29207885
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Med Sci Sports Exerc. 2018 Feb;50(2):257-265
pubmed: 28976493
Nat Rev Rheumatol. 2011 Apr;7(4):216-24
pubmed: 21283147
J Behav Med. 2000 Aug;23(4):351-65
pubmed: 10984864
J Physiother. 2017 Apr;63(2):120
pubmed: 28325480
BMJ. 2006 Jun 17;332(7555):1430-4
pubmed: 16777886
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
Perspect Clin Res. 2011 Jul;2(3):109-12
pubmed: 21897887
JMIR Mhealth Uhealth. 2015 Nov 19;3(4):e96
pubmed: 26586418
Global Spine J. 2015 Dec;5(6):496-504
pubmed: 26682100
Am J Public Health. 1995 May;85(5):706-10
pubmed: 7733433
Arthritis Rheum. 2012 Jun;64(6):2028-37
pubmed: 22231424
Rev Saude Publica. 2015;49:
pubmed: 26487293
Br J Sports Med. 2012 Mar;46(4):224-7
pubmed: 21821612
BMC Med Res Methodol. 2010 Jan 06;10:1
pubmed: 20053272
Arthritis Rheum. 2008 May 15;59(5):632-41
pubmed: 18438893
Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:5892-5
pubmed: 25571337
Med Sci Sports Exerc. 2008 Jul;40(7 Suppl):S537-43
pubmed: 18562971
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Med Sci Sports Exerc. 2011 Jun;43(6):1085-93
pubmed: 21088628
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
J Sport Health Sci. 2019 Jul;8(4):386-393
pubmed: 31333893
Spine (Phila Pa 1976). 2012 May 15;37(11):E668-77
pubmed: 22146287
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Eur Spine J. 2010 Dec;19(12):2075-94
pubmed: 20602122
Psychopathology. 1998;31(3):160-8
pubmed: 9636945
Sensors (Basel). 2013 Jul 17;13(7):9183-200
pubmed: 23867744
Sports Med. 2004;34(1):1-8
pubmed: 14715035
PLoS One. 2016 Sep 02;11(9):e0161224
pubmed: 27589592
Phys Ther. 2001 Feb;81(2):776-88
pubmed: 11175676
Physiol Meas. 2017 Jan;38(1):N1-N15
pubmed: 27941238
IEEE Trans Biomed Eng. 1985 Mar;32(3):230-6
pubmed: 3997178
Ann Fam Med. 2014 Mar-Apr;12(2):102-11
pubmed: 24615305
Clin J Pain. 2013 Nov;29(11):972-81
pubmed: 23446066
Sports Med. 1994 Jan;17(1):39-52
pubmed: 8153498
Int J Cardiol. 2015 Apr 15;185:138-40
pubmed: 25795203
J Med Internet Res. 2013 Aug 19;15(8):e181
pubmed: 23969029
Gait Posture. 2017 Mar;53:11-16
pubmed: 28064084
Musculoskelet Sci Pract. 2018 Apr;34:38-46
pubmed: 29257996
J Clin Nurs. 2001 Sep;10(5):697-706
pubmed: 11822520
Phys Ther Sport. 2019 Mar;36:34-42
pubmed: 30620922
J Phys Act Health. 2011 Jan;8(1):45-51
pubmed: 21297184
J Behav Med. 1997 Dec;20(6):589-605
pubmed: 9429990
Hong Kong Physiother J. 2015 Dec;33(2):73-79
pubmed: 30930571
PLoS One. 2011;6(7):e22922
pubmed: 21829556
J Spinal Disord. 2000 Jun;13(3):205-17
pubmed: 10872758
Am J Epidemiol. 2011 Aug 1;174(3):267-73
pubmed: 21633119